Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROZANOLIXIZUMAB vs RUBIDIUM RB-82: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROZANOLIXIZUMAB vs RUBIDIUM RB-82: Safety Overview

Metric ROZANOLIXIZUMAB RUBIDIUM RB-82
Total FAERS Reports 303 138
Deaths Reported 9 0
Death Rate 3.0% N/A
Hospitalizations 114 2
Average Patient Age 61.3 yrs 66.9 yrs
% Female Patients 60.9% 50.4%
FDA Approval Date N/A Dec 29, 1989
Manufacturer UCB, Inc. Jubilant DraxImage Inc., dba Jubilant...
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status N/A Prescription